The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Michigan Ovarian Cancer Alliance
Grant: Pilot Ilana Chefetz
The Foundation for Women’s Cancer
Grant: Ilana Chefetz
National Institutes of Health
Grant: 1R01CA218026
National Institutes of Health
Grant: 5R01CA238315-02
ALDH Inhibition as Modulator of Tumor Immunobiology
FWCI
4.22
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals